Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleHuman Studies

A Diagnostic Approach in Alzheimer's Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET

Satoshi Minoshima, Kirk A. Frey, Robert A. Koeppe, Norman L. Foster and David E. Kuhl
Journal of Nuclear Medicine July 1995, 36 (7) 1238-1248;
Satoshi Minoshima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirk A. Frey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert A. Koeppe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman L. Foster
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David E. Kuhl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 36, Issue 7
July 1, 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Diagnostic Approach in Alzheimer's Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Diagnostic Approach in Alzheimer's Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET
Satoshi Minoshima, Kirk A. Frey, Robert A. Koeppe, Norman L. Foster, David E. Kuhl
Journal of Nuclear Medicine Jul 1995, 36 (7) 1238-1248;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Diagnostic Approach in Alzheimer's Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET
Satoshi Minoshima, Kirk A. Frey, Robert A. Koeppe, Norman L. Foster, David E. Kuhl
Journal of Nuclear Medicine Jul 1995, 36 (7) 1238-1248;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Glycolysis-enhancing {alpha}1-adrenergic antagonists are neuroprotective in Alzheimers disease
  • Assessment and staging of A/T/N with a single dynamic [18F]PI-2620 recording
  • SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
  • Improving 18F-FDG PET Quantification Through a Spatial Normalization Method
  • Influence of Minimum Count in Brain Perfusion SPECT: Phantom and Clinical Studies
  • Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome
  • 18F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies
  • Striatal Acetylcholine-Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET-Informed Correlational Tractography
  • Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis
  • Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere-Predominant Logopenic Progressive Aphasia
  • Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography
  • Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
  • Longitudinal anatomic, functional, and molecular characterization of Pick disease phenotypes
  • A Pioneering Paper That Provided a Tool for Accurate, Observer-Independent Analysis of 18F-FDG Brain Scans in Neurodegenerative Dementias (perspective on "A Diagnostic Approach in Alzheimers Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET" J Nucl Med. 1995;36:1238-1248)
  • Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
  • Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia
  • Selective neuronal damage and blood pressure in atherosclerotic major cerebral artery disease
  • Decoupling of inter-regional functional connectivity and regional neural activity in Alzheimer Disease
  • Deep learning-based imaging classification identified cingulate island sign in dementia with Lewy bodies
  • Current Status of 18F-FDG PET Brain Imaging in Patients with Dementia
  • Early-stage right temporal lobe variant of frontotemporal dementia: 3 years of follow-up observations
  • Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study
  • 18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
  • Is Tau Imaging More Than Just Upside-Down 18F-FDG Imaging?
  • Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis
  • Progressive Cortical Neuronal Damage and Extracranial-Intracranial Bypass Surgery in Patients with Misery Perfusion
  • Effect of non-pharmacological intervention for apathy: response to one-on-one reminiscence-based intervention
  • Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth
  • Progressive Cortical Neuronal Damage and Chronic Hemodynamic Impairment in Atherosclerotic Major Cerebral Artery Disease
  • Genetic and Environmental Influences on Regional Brain Uptake of 18F-FDG: A PET Study on Monozygotic and Dizygotic Twins
  • Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment
  • Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction
  • 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias
  • Comparing brain structural MRI and metabolic FDG-PET changes in patients with ALS-FTD: 'the chicken or the egg?' question
  • Metabolic Activity of Red Nucleus and Its Correlation with Cerebral Cortex and Cerebellum: A Study Using a High-Resolution Semiconductor PET System
  • Establishing Amyloid PET Imaging Biomarkers: Ongoing Efforts
  • 18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
  • MR-Based Attenuation Correction Using Ultrashort-Echo-Time Pulse Sequences in Dementia Patients
  • PET Approaches for Diagnosis of Dementia
  • Activity of P-Glycoprotein, a {beta}-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease
  • Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for 18F-FDG Brain Imaging in Patients Examined for Suspected Dementia
  • Potential for misdiagnosis in community-acquired PET scans for dementia
  • Implementation and Validation of an Adaptive Template Registration Method for 18F-Flutemetamol Imaging Data
  • Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited
  • FDG-PET and molecular brain imaging in the movement disorders clinic
  • [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism
  • Gender Modulates the APOE {varepsilon}4 Effect in Healthy Older Adults: Convergent Evidence from Functional Brain Connectivity and Spinal Fluid Tau Levels
  • Inclusion criteria provide heterogeneity in baseline profiles of patients with mild cognitive impairment: comparison of two prospective cohort studies
  • Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin
  • Summary Metrics to Assess Alzheimer Disease-Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison
  • Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature
  • Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
  • Effect of Prefiltering Cutoff Frequency and Scatter and Attenuation Corrections During Normal Database Creation for Statistical Imaging Analysis of the Brain
  • Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study
  • Computer-Assisted System for Diagnosis of Alzheimer Disease Using Data Base- Independent Estimation and Fluorodeoxyglucose- Positron-Emission Tomography and 3D-Stereotactic Surface Projection
  • Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery
  • Hereditary spastic paraplegia caused by the PLP1 'rumpshaker mutation'
  • Cerebral single photon emission computer tomography in thalamic lacunar infarction presenting with amnesia
  • Parkinsonism with organophosphate poisoning
  • Differential SPECT Activation Patterns Associated with PASAT Performance May Indicate Frontocerebellar Functional Dissociation in Chronic Mild Traumatic Brain Injury
  • Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease
  • Postoperative Cortical Neural Loss Associated With Cerebral Hyperperfusion and Cognitive Impairment After Carotid Endarterectomy: 123I-iomazenil SPECT Study
  • Brain Adenosine A2A Receptor Occupancy by a Novel A1/A2A Receptor Antagonist, ASP5854, in Rhesus Monkeys: Relationship to Anticataleptic Effect
  • Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons
  • Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
  • Comparison of 18F-FDG PET and Optimized Voxel-Based Morphometry for Detection of Alzheimer's Disease: Aging Effect on Diagnostic Performance
  • Evaluation of Probable or Possible Dementia with Lewy Bodies Using 123I-IMP Brain Perfusion SPECT, 123I-MIBG, and 99mTc-MIBI Myocardial SPECT
  • Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
  • 18F-FDG PET Database of Longitudinally Confirmed Healthy Elderly Individuals Improves Detection of Mild Cognitive Impairment and Alzheimer's Disease
  • Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease
  • Hypometabolism Exceeds Atrophy in Presymptomatic Early-Onset Familial Alzheimer's Disease
  • Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography
  • Early clinical signs and imaging findings in Gerstmann-Straussler-Scheinker syndrome (Pro102Leu)
  • Prediction of Individual Clinical Outcome in MCI by Means of Genetic Assessment and 18F-FDG PET
  • APOE related alterations in cerebral activation even at college age
  • Rapid Scanning Protocol for Brain 18F-FDG PET: A Validation Study
  • Reduced hippocampal metabolism in MCI and AD: Automated FDG-PET image analysis
  • From The Cover: Correlations between apolipoprotein E {epsilon}4 gene dose and brain-imaging measurements of regional hypometabolism
  • 11C-DTBZ and 18F-FDG PET Measures in Differentiating Dementias
  • Cerebral glucose metabolism in patients with AD and different APOE genotypes
  • Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement
  • Superiority of 3-Dimensional Stereotactic Surface Projection Analysis over Visual Inspection in Discrimination of Patients with Very Early Alzheimer's Disease from Controls Using Brain Perfusion SPECT
  • Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis
  • Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
  • Software Approach to Merging Molecular with Anatomic Information
  • Correction for Partial-Volume Effects on Brain Perfusion SPECT in Healthy Men
  • Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome
  • Qualitative versus Quantitative Assessment of Cerebrovascular Reactivity to Acetazolamide Using iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in Patients with Unilateral Major Cerebral Artery Occlusive Disease
  • Prediction of Hyperperfusion After Carotid Endarterectomy by Brain SPECT Analysis With Semiquantitative Statistical Mapping Method
  • Quantitative Measurement of Regional Cerebrovascular Reactivity to Acetazolamide Using 123I-N-Isopropyl-p-Iodoamphetamine Autoradiography with SPECT: Validation Study Using H215O with PET
  • Statistical Image Analysis of Cerebral Blood Flow in Vascular Dementia with Small-Vessel Disease
  • Direct Comparison of Spatially Normalized PET and SPECT Scans in Alzheimer's Disease
  • Inhibition of Protein Phosphatase 2A Overrides Tau Protein Kinase I/Glycogen Synthase Kinase 3{beta} and Cyclin-dependent Kinase 5 Inhibition and Results in Tau Hyperphosphorylation in the Hippocampus of Starved Mouse
  • Statistical Brain Mapping of 18F-FDG PET in Alzheimer's Disease: Validation of Anatomic Standardization for Atrophied Brains
  • Three-Dimensional Stereotactic Surface Projection Analysis of Macaque Brain PET: Development and Initial Applications
  • FDG PET Imaging in Patients with Pathologically Verified Dementia
  • Google Scholar

More in this TOC Section

  • Detection of Postoperative Deep-Venous Thrombosis Using Technetium-99m-Labeled Tissue Plasminogen Activator
  • Fatty Acid Metabolic Imaging with Iodine-123-BMIPP for the Diagnosis of Coronary Artery Disease
  • The Role of Thallium-201 Uptake and Retention in Intracranial Tumors After Radiotherapy
Show more Human Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire